Intermediate-term outcome of cryoballoon ablation of persistent atrial fibrillation and improvements in quality of life of patients.
Daniel MolAnchee M BoersmaWouter R BergerMuchtiar KhanGijsbert S de RuiterGeert-Jan P KimmanJoris R de GrootJonas S S G de JongPublished in: PloS one (2022)
There is a considerable ATa recurrence rate after PVI of persistent AF at intermediate-term follow-up. However, our data indicate that PVI significantly improved AF-related symptoms and resulted in a high HRQoL for 2-5 years in patients with persistent AF.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- oral anticoagulants
- end stage renal disease
- left atrial appendage
- direct oral anticoagulants
- heart failure
- preterm infants
- ejection fraction
- chronic kidney disease
- newly diagnosed
- percutaneous coronary intervention
- peritoneal dialysis
- prognostic factors
- radiofrequency ablation
- electronic health record
- physical activity
- patient reported outcomes
- left ventricular
- deep learning
- data analysis